Employers Holdings Earnings Call Transcripts
Fiscal Year 2026
-
Disciplined underwriting led to improved expense ratios and 8.9% book value growth, despite a 15% drop in gross premiums written. Shareholder returns remained strong, with $83 million returned and new AI-driven initiatives launched to support future growth.
Fiscal Year 2025
-
Q4 2025 saw an 11% drop in gross premiums written and higher losses, but book value per share rose 11% as capital was returned to shareholders. AI-driven product launches and operational efficiencies are expected to drive future growth despite a challenging California market.
-
Reserve strengthening for California CT claims drove a quarterly adjusted net loss, despite premium growth and strong policy retention. Expense reductions, a recapitalization plan, and new product initiatives support future profitability and diversification.
-
Net premiums earned rose 5.6% year-over-year, while gross written premium declined 2.2% due to targeted underwriting. Adjusted net income fell 58.8% amid rising cumulative trauma claims in California, prompting reserve reallocations and a planned actuarial study.
-
Net premiums earned were flat, but investment income hit a record high and adjusted net income rose 24%. Loss ratios increased due to competitive pressures and rising cumulative trauma claims in California. A new $125M buyback and a 7% dividend hike reflect strong financial confidence.
Fiscal Year 2024
-
Record highs in premium and investment income were achieved in 2024, with strong underwriting profit and improved expense ratios. The outlook for 2025 includes a higher loss and LAE ratio due to industry trends, but ongoing expense reductions and digital expansion are expected to support growth.
-
Net income per share surged 124% year-over-year, with adjusted net income per share up 19%, driven by higher earned premiums and investment gains. Book value per share reached record highs, and appetite expansion fueled a 7% year-to-date premium increase.
-
Adjusted net income per share reached $1.10, with strong premium growth and investment income driving revenue gains. Expense ratios improved significantly, and capital was returned to shareholders via dividends and buybacks. Medical inflation risks are mitigated by fee schedules, though legislative changes in Florida may increase costs.